The Potential of Combined Immunotherapy and Antiangiogenesis for the Synergistic Treatment of Advanced NSCLC

Overview of attention for article published in Journal of Thoracic Oncology, October 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 34,012 followers.

RT @OncologyAdvance: Focus on immunotherapy in lung cancer at #ASCO18 today, with @peters_solange. Read related @JTOonline article https://…

RT @OncologyAdvance: Focus on immunotherapy in lung cancer at #ASCO18 today, with @peters_solange. Read related @JTOonline article https://…

RT @OncologyAdvance: Focus on immunotherapy in lung cancer at #ASCO18 today, with @peters_solange. Read related @JTOonline article https://…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.